{
    "title": "GSK's two-drug HIV Dovato treatment meets main goal in study (July 10)",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7232929/GSKs-two-drug-HIV-Dovato-treatment-meets-main-goal-study.html",
    "date": "2019-07-10",
    "keywords": [
        "hiv",
        "dovato",
        "treatment",
        "virus",
        "combination",
        "viiv",
        "dolutegravir",
        "lamivudine",
        "market",
        "study",
        "gsk",
        "hiv1",
        "twodrug",
        "level",
        "threedrug",
        "latestage",
        "trial",
        "drugmaker",
        "wednesday",
        "april",
        "analyst",
        "graham",
        "doyle",
        "data",
        "package",
        "drug",
        "shift",
        "therapy",
        "side",
        "effectiveness",
        "companys",
        "division",
        "resistance",
        "pfizer",
        "inc",
        "shionogi",
        "co",
        "ltd",
        "group",
        "profit",
        "year",
        "category",
        "bodys",
        "immune",
        "system",
        "reporting",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "bernard",
        "orr"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}